SEC Filing Details

Document Details

Form

Filing Date

05/18/2023

Document Date

05/16/2023

Form Description

Statement of changes in beneficial ownership of securities

Filing Group

3,4,5

Company

Eagle Pharmaceuticals, Inc.

Issuer

EAGLE PHARMACEUTICALS, INC.

View HTML

Change % Volume Data as of 03/31/2023 11:39 PM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.